Classical immunology textbooks have described the central nervous system as an immune-privileged site, Le., as devoid of inflammatory and host-vs.-graft immunoreactions. This view has been refined, since we now know that hematopoietic cells infiltrate the CNS under certain circumstances and that CNS-resident cells are capable of launching an innate immune response. Microglia cells express an extensive repertoire of pattern-recognition receptors and act as sentinels surveilling the CNS for possible damage or infection. Astrocytes are the most abundant cell type in the brain, and they are capable of launching a strong supportive innate immune response. Novel findings show that both astrocytes and, surprisingly, even neurons express pattern-recognition receptors. Activation of these receptors leads to a functional response, indicating that cells other than microglia are capable of initiating a primary innate immune response against CNS-invading pathogens. Here, we put these findings into context with what has been learned from recent in vitro and in vivo experiments about the initiation of an innate immune response in the brain.
Historically, the CNS was described as an immune-privileged site based on the tolerance of the brain to a skin graft (Medawar, 1948) . In addition, the brain appeared to lack a draining lymphatic system, combined with the presence of a blood-brain barrier and a low expression of m'\ior histocompatibility complex (MHC) molecules on C NS-resident cells. In recent years, this view has been altered dramatically, and we now know that petipheral immune cells can migrate into the brain and affect the course of CNS diseases or even be major players in neuropathological events (Becher et aI., 2006; Simard et aI., 2006; Priller et aI., 2006) . Cell infiltration is often limited to the vessel walls or perivascular spaces (Bechmann et aI., 2007) , and CNS-residing cells regulate the entry of blood-borne immune cells into the brain parenchyma and modulate their response, be it adaptive or innate. This is partially achieved by the release of pro-and antiinflammatory cytokines and chemokines capable of attracting peripheral immune cells (Heppner et aI., 2005; Owens et aI., 2001 ). In addition, CNS cells can regulate the survival of infiltrating cells once they have entered the brain parenchyma. A more accurate term would be to describe the CNS as an "immune-attenuated" site. References on the function of CNS-infiltrating immune cells can be found elsewhere (Becher et aI. , 2006; Simard et aI., 2006; Bechmann et al., 2007) . Here, we describe how CNS-resident cells detect microorganisms and initiate an innate immune response.
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Fig. 1. Different types of pathogen-recognition receptors and their subcellular localization. Toll-like receptors (TLRs) are found on the cell surface and on the membrane of intracellular organelles, where they recognize internalized PAM Ps; scavenger receptors are a heterogeneous group of receptor f:1milies (types A-H) characterized by the unifying property to bind to oxidized LDL. CD36 is an example of a B-type scavenger receptor; complement receptors (complement R) act together with their primary ligand, activated complement f:1ctors extracellular PRRs, where the membrane signaling components (i.e., the complement receptors) are dissociated from the detection and effector component (soluble complement factors). In addition, several intracellular PRRs have been identified, capable of detecting P AMPs in different intracellular compartments (Meylan et al., 2006) .
The TLRs
Ten members of the TLR family (Medzhitov and Janeway, 2002) have been identified in humans and 12 in mice (Akira et a!., 2006) . Toll, the initial member of the TLR family, was first identified in Drosophila melanogaster as a type-l receptor with an intracellular domain similar to that of the interleukin-l receptor. Mutation of the Toll receptor and the downstream signaling components cactus and dorsal (homologues of IKE and NF-KE) led to an increased susceptibility to fungal infections and decreased survival upon fungal infection (Lemaitre et a!., 1996) . TLRs are glycosylated type-l integral membrane proteins with a molecular mass ranging from 90 to 115 kDa. TLRs can be divided into subgroups based on the molecules that they recognize . For instance, TLR1, TLR2, TLR4, and TLR6 recognize modified lipids; TLR5 recognizes bacterial flagellin; and TLRll recog-
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nizes profliin-like molecules from Toxoplasma gondii (for a more extensive review on TLR ligands see Akira et al., 2006, and Fig. 2) . Some TLRs display high ligand selectivity. TLR3 recognizes viral double-stranded RNA; TLR7 and TLR8 recognize single stranded vIral RNA; and TLR9 recognizes viral DNA and bacterial nonmethylated epG-containing DNA motifs . Other receptors are much less selective in their ligand recognition. TLR2 and TLR4 recognize a wide variety of lipids, glycolipids, and envelope proteins. They can even be stimulated by host-derived molecules such as chaperones or S100 proteins (Akira et a!., 2006) and may thus take a role in chronic neurodegeneration and regenerative processes in the brain (Rolls et al., 2007; Tang et a!., 2007) .
TLRs are associated as hetero-and homodimers in the absence of ligands, interacting via their extracellular domains (Ozinsky et a!., 2000; Mizel et a!., 2003) . The cellular response to stimulation with a given ligand depends strongly on the TLR receptor composition. Activation of homodimerized TLR4 triggers a signaling cascade that ultimately leads to the production of tumor necrosis factor (TNF) in macrophages. In contrast, activation of homodimerized TLR1, TLR2, or TLR6 does not. However, stimulation of heterogeneous receptor complexes consisting of TLR2 dimerized with either 
en Intra-cellular receptors
Toll-like receptors C-type Lectins TLR1 or TLR6 does lead to the production of TNF (Ozinsky et al., 2000) . TLRs are expressed predominantly on the cell surface, but the nucleic acid-detecting receptors TLR3, TLR7, TLR8, and TLR9 are also highly expressed on endosomes. The ratio of relative surface to endosomal expression varies for different cell types (Ozinsky et aI., 2000; Akira et aI. , 2006) .
TLR Signal Transduction
The complexity of TLR signaling is increased by the fact that other coreceptors are involved in the binding and signaling of PAMPs. Lipopolysaccharide (LPS), a cell-wall constituent of gram-negative bacteria, is a pharmacological ligand of TLR4. In a physiological context, LPS is initially bound in the plasma by LPS binding protein (LBP) and from there transferred to a glycosylphosphatidylinositol (GPI)-anchored molecule (CD14) expressed on the surface of macrophages. An intracellular signaling cascade is subsequently initiated through a receptor complex consisting of TLR4 and the coreceptor MD-2 (Nagai et aI., 2002; Akashi et aI., 2003; Fig. 3) .
TLR signaling requires various intracellular adaptor molecules to activate divergent pathways (Fig. 4) . The normal form of LPS (termed "smooth") activates both MyD88/TlRAP and TRIF/TRAM in a CD14-dependent manner, whereas the mutant short-form of LPS in cytosine and guanine bases; UBP, unspecified products of uropathogenic bacteria; CARD, caspase recruitment domain; TIR, Toll/ IL-l R domain; ITAM, immunoreceptor tyrosine-based activation motif; SYK, L YN, FYN (common to all C -type lectins), receptor linked tyrosine kinases; MALT1-Bcll0, mucosa associated lymphoid tisslle lymphoma translocation protein-B cell lymphoma 10; Fey receptor, complement receptor; ds/ss, double stranded/single stranded.
("rough") activates MyD88/TlRAP in a CD14-independent manner Giang et aI., 2005; Fig. 3 ).
Activation of TLR2 and TLR4 eventually leads to the downstream activation of NF-KB and MAP kinases (Akira et al., 2006; O'Neill, 2006 ; and references therein). NF-KB and MAP kinases (see Fig, 4 ) are master regulators of innate and adaptive immunity as well as cell survival. MyD88 is a vital signaling component for most TLRs (except for TLR3), but the MyD88-TLR bridging molecule TlRAP is dispensable for MyD88 recruitment to TLR5, -7, -8, and -9 (Oshiumi et aI., 2003) . TLR4 Myd88-independent signaling is mediated via TRIF using TRAM as a bridging molecule, whereas TLR3 functions through TRIF in a TRAM-independent fashion (Yamamoto et aI., 2003) . This ultimately leads to IRF-3 and IRF-7 phosphorylation (Hacker et aI., 2006) . IRF3 and IRF7 are essential for the production of type-1 interferons (IFN), potent antiviral factors (Honda et aI., 2005) . In addition, IFN-regulatory factor 5 (IRF5), a downstream MyD88-regulated transcription factor, is essential for interleukin (IL)-6, IL-12, and TNF expression (Takaoka et aI., 2005 for downstream TLR signaling (Bsibi et aI., . 2002; Kielian et al ., 2002; Olson and Miller, 2004; Jack et aI., 2005; Mishra et aI., 2006; Town et aI., 2006) . Activation of microglia leads to an increased expression of TLRs (Kielian et aI., 2002; Olson and Miller, 2004; Jack et aI., 2005) . These observations are well in line with the expected role of microglia as the main cell type responsible for the primary defense against pathogens entering the brain. Already in a simplified model, using only one artificial ligand, TLR -induced microglia response typically leads to the production of antiviral/bacterial molecules such as TNF, IFN-[3, inducible nitric oxide synthetase, and a multitude of chemokines and pro-and antiinflammatory interleukins, as well as cell proliferation (Olson and Miller, 2004; Lund et al., 2006) . Microglia react to a single specific stimulation of either TLR2 or TLR 4 by lipoteichoic acid (LTA) or LPS, respectively, with the release of proinflammatory cytokines (Lund et aI., 2005) . Costimulation of microglia with concentrations of two or more TLR ligands that individually lead to a submaximal stimulus can induce a synergistic response (Ebert et aI., 2005) . Microglia stimulated with combinations of two different TLR2 or TLR4 ligands or combinations of TLR2/TLR4, TLR4/TLR9, and TLR2/ 1437 TLR9 ligands release nitric oxide in a synergistic fashion. This observation may be important for an effective host defense, in that individual microorganisms express ligands for multiple TLR receptors. Peptidoglycans (PGN) or L T A from Staphylococcus aureus may activate microglia via TLR2, but TLR2 expression is not essential for recognition of the intact gram-positive bacteria (Kielian et aI. , 2005b) . Deletion of TLR2 led to a decrease in the pro inflammatory cytokine production in Staphylococcus aureus-infected CNS tissue. Despite this viability, the number of brain abscesses and the titer of gram-positive bacteria are not affected in TLR2-deficient mice (Kielian et aI., 2005a) .
Inadvertent Functional Consequences of TLR Activation on Microglia
In vitro, activation of microglia can result in bystander toxicity of cocultured neurons or oligodendrocytes (Lehnardt et aI., 2002 (Lehnardt et aI., , 2003 (Lehnardt et aI., , 2006 Iliev et aI., 2004) . Intracerebroventricular administration of LPS leads to an increased leukocyte recruitment to the brain via CD14-TLR4 activation in both an MyD88-dependent and an MyD88-independent fashion (H. Zhou et aI., 2006) . Intracerebral injection of LPS causes rapid and progressive demyelination and neurotoxicity via TLR 4 (Lehnardt et aI., 2002; Nadeau et aI., 2003) . LPSinduced neurodegeneration is partially actuated by TNF but is reduced by an endogenous glucocorticoid response in the CNS, which suggests that endogenous mechanisms exist for keeping the innate immune response in check (Nadeau et al., 2003) . Peripheral LPS administration, used as a model for sepsis, also induces a strong and chronic pro inflammatory CNS response. Despite the delivery of LPS to the periphery, this response requires the expression of TLR4 in the CNS compartment (Chakravarty and Herkenham, 2005) . Eventually, such mice develop a delayed, progressive loss of dopaminergic neurons in the substantia nigra, showing that peripheral infections have the capability to induce or augment CNS pathology (Qin et aI., 2007) . Roles of the TLRdriven innate immune response, beyond pathogen recognition, are suggested by reports that TLR expression on microglia promotes the clearance of [3-amyloid peptide in amyloid precursor protein (APP) transgenic mice and in vitro and that stimulation of TLR9 antagonizes glioma formation (Tahara et aI., 2006; EI Andaloussi et aI., 2006).
TLRs on Astrocytes
Within the last few years, it has become apparent that nonmyeloid CNS-residing cells express TLRs. Astrocytes express constitutively high levels of TLR3 and the adaptor molecules required for TLR signaling (Farina et aI., 2005; Jack et aI., 2005) . As opposed to microglia, which mainly express TLR3 in intracellular compartments, astrocytes appear to have both a high intracellular and a high surface expression of TLR3. This possibly reflects the fact that astrocytes are not professio- (Carpentier et al., 2005; Farina et al ., 2005; Jack et al., 2005; Scumpia et al., 2005; Bsibsi et al., 2006) . Stimulation of TLR3 with the dsRNA-mimetic TLR3 ligand polyinosinic-cytidyli c acid [poly(I: C)J leads to a proinflammatory response with many similarities to a microglial TLR response . Upon TLR-3 activation, TNF, IFN-I3 , inducible nitric oxide synthetase, and a multitude of chemokines and pro-and antiinflammatory ILs as well as IFNregulated antiviral molecules are induced (Scumpia et al., 2005; Bsibsi et al., 2006; So et al ., 2006) . A similar response is observed when astrocytes are activated by cytokines Oohn et al., 2005; Falsig et al., 2006) . Stimulation of astrocytes with poly(I:C) decreases glutamate uptake by astrocytes, suggesting that an astrocytic response to poly(I:C) may indirectly affect neuronal function and viability (Scumpia et al., 2005) . In a different experimental setup, conditioned medium from poly(I:C) -treated astrocytes was found to be neuroprotective for cortical brain slice cultures (Bsibsi et al., 2006) . The main role of astrocyte TLRs may lie in viral defense, insofar as poly(I:C) treatment triggers protection proteins, RICK, [RAK kinases, TA NK-binding kinase-l (TI3Kl), MAP kinases, and inhibitor of NF-KB kinases (IKK). Ultimately, the signa l transduction results in th e activation of transcription f.1ctors that trigger diflcrent panels of inflanmlatory/ host response genes.
of astrocytes from an infection in vitro. For instance, poly(I:C) induces the production of an antiviral molecule, Viperinl cig5, that inhibited the replication of a pseudotyped human immunodeficiency virus (HIV) viral particle in astrocytes (Rivieccio et al., 2006) . Poly(I:C) -induced viperin expression was prevented with IFN-I3-neutralizing antibodies, by inhibiting NF-Kl3 and IRF3, and by a specific viperin knockdown using RNA interference . In all cases, a decrease in viperin expression correlated with an increased viral titter (Rivieccio et al., 2006 ). Theiler's murine encephalomyelitis virus (TMEV), an experimental model for a virus-mediated demyelinating disease, induces a proinfianunatory response in TMEVinfected astrocytes. In astrocytes devoid of TLR3, this response is reduced, but the lack of an infiammatOlY response does not affect the replication of the virus within astrocytes (So et al., 2006) .
Comparing a response of cells infected with a virus and cells treated with purified TLR ligands has certain drawbacks. One of the main concerns associated with using purified TLR ligands as an experimental tool is the purity and specificity of the ligands. Impurities can often be found in LPS preparations (Werts et al ., 2001) , and many other ligand preparations have in the past often been contaminated with LPS. Even when a ligand preparation is pure, the ligand is not necessarily specific for a given receptor. Poly(I:C), a ligand commonly used to study TLR3 function, stimulates TLR3 when applied extracellularly. On the other hand, cytoplasmic delivery of poly(I:C) stimulates the activation of protein kinase R (PKR) and a novel PRR, retinoic acid-inducible gene I (RIG-I; Gunnery and Mathews, 1998; Matsumoto et aI., 2002; Yoneyama et aI., 2004) . This is substantiated by the observation that poly(I:C) induces a robust, although reduced, microglial cytokine response in TLR3-/-mice compared with wild type (wt; Town et aI., 2006) .
Discussion of the signaling of TLR in astrocytes is still controversial, because pharmacological tools used to dissect signaling cascades mostly lack absolute specificity, and knockouts may induce compensatory responses allowing for alternative signaling pathways. For instance, poly(I:C) activates PKR in astrocytes, and pharmacological inhibition of PKR was shown to block the poly(I:C)-mediated production of nitric oxide and cytokines. The authors suggested that PKR acted as a downstream effector of a membrane receptor (likely TLR3; Scumpia et aI., 2005). Recently, this hypothesis was disputed by showing that PKR -/ -astrocytes respond normally to poly(I:C) treatment, suggesting that PKR does .not play a significant role in TLR3 signaling in astrocytes (Carpentier et aI., 2007) . Also, not all signaling observations correlate with functional consequences. For instance, TMEV activation of astrocytes was shown to be dependent on PKR (not on TLR3). However, no difference in viral replication was detected between wt and PKR-null cells (Carpentier et al., 2007; Fig. 5 ).
Functional Implication of Astrocyte TLR Receptors
Little is known about the importance of TLR3 expression on astrocytes in vivo . Intracerebral or peripheral administration of poly(I :C) leads to a strong activation of microglia and astrocytes. These findings prompted the authors to suggest that poly(I:C) activates astrocytes in vivo (Zhang et al., 2005; Town et aI., 2006) . A pitfall of these studies is that many microgliaderived factors strongly affect the activation state of other CNS residing cells Oohn et aI., 2005) . Microglial release of TNF and IL-l induces a strong production of cytokines and chemokines in astrocytes in vivo, leading to the attraction of microglia and peripheral immune cells 1439 to the site of infection/damage (Babcock et al., 2003; Marella et aI., 2005) . In the previously mentioned in vivo studies, astrocytes were possibly activated indirectly through microglia, indicated by the fact that astrocytes were also strongly activated by LPS, a TLR4 ligand that is relatively microglia specific (Town et a!., 2006) . Low levels of TLR4 expression on astrocytes in vitro have been described throughout the literature, but in vivo astrocytes do not appear to express TLR4 (Lehnardt et a!., 2002; Ma et aI., 2006; Mishra et aI., 2006) . TLR4 activation by LPS leads to highly variable functional astrocytic responses, possibly because of varying preactivation states of astrocyte cultures, and different states of TLR up-regulation by the preactivation (Lee et aI., 1993; Bowman et aI., 2003; Esen et al., 2004; Carpentier et aI., 2005; Farina et aI., 2005; Bsibsi et al., 2006) . For instance, rat astrocytes have been r~ported to respond strongly to LPS but also to be devoid of receptor expression and LPS binding (Chung and Benveniste, 1990; Lehnardt et aI., 2002) . Human astrocytes have been reported to show an increased mRNA expression in response to LPS stimulation but to a much lesser extend than the response shown after poly(I:C) stimulation (Bsibsi et aI., 2006) . Concerning the production of polypeptide mediators (e.g., cytokines), astrocytes were found either to be unresponsive to LPS stimulation (Lee et aI., 1993) or to release less than 10% of IL-6 compared with that released by poly(I:C)-stimulated astrocytes (Farina et al., 2005) . Also, reports of TLR4-mediated functional responses on murine astrocytes vary enormously. In our hands, we see no effect of LPS stimulation on purified astrocytes from C57BLl6 mice (Falsig et aI., 2004) . Other groups reported effects on murine astrocytes (Bowman et aI., 2003; Esen et aI., 2004; Carpentier et aI., 2005) , but none of the studies showed that . the LPS-induced effects are dependent on TLR4 expression on astrocytes. Furthermore, two of the studies show maximal astrocyte activation at concentrations of 0.01 or 1 ng/ml of LPS. These concentrations are at least 1,000-fold below what is needed to activate microglia via TLR maximally and thus point to a different mechanism on the astrocytes of these studies (Lee et al., 1993; Bowman et a!., 2003; Esen et aI., 2004) .
The expression pattern of multiple TLR receptors is modulated by pro inflammatory stimulation of microglia and astrocytes. Especially TLR2 expression on astrocytes is induced by stimulation with TLR3 ligands and cytokines in vitro (Bowman et , 2006) . Few reports of TLR2 function on astrocytes have been reported, so whether the up-regulation of TLR2 has any functional consequences is at this point unknown. One report suggests that pure astrocyte cultures depleted of microglia using a gliotoxin can respond strongly to TLR2 stimulation induced by Staphylococcus aureus or its cell wall constituent PGN (Esen et al., 2004) . In addition, soluble CD14 was recently reported to activate astrocytes through TLR2 (Bsibsi et aI., 2007) . However, the role of TLR2 in astrocyte ac tivation requires further characterization. TLR5 and TLR9 expression has been reported on astrocytes in vitro and TLR6 and TLR7 in vivo, but functional roles still have to be elucidated (Bsibsi et al., 2002; Mishra et aI., 2006) .
TLRs on Oligodendrocytes and Neurons
Not much is known about TLR expression on oligodendrocytes, but mRNA expression for TLR2 and TLR3 and immunoreactivity for TLR2 have been described (Bsibi et aI. , 2002; Lehnardt et al., 2006) . Recently, TLR3 expression on Purkinj e neurons in the cerebellar cortex of post-mortem tissues from patients suffering from chronic or infectious neuropathies was reported Oackson et al., 2006) . In addition, rabies virus with TLR3 stimulation with poly(I:C) was shown to induce the release of IFN-13 in neurons (a terminally differentiated human cell line; Prehaud et al., 2005) . Even more surprising, TLR8 expression was demonstrated on embryonic and early postnatal neurons in vivo by immunocytochemistry and in situ hybridization, suggesting a role for TLRs in neurodevelopment (Ma et aI. , 2006) . It was shown that TLR8 is expressed on cortical neurons in vitro and that stimulation with the TLR8 ligand R -848 leads to apoptosis and inhibition of neurite outgrowth independent of NF-KB ac tivation . It will be exciting to see whether primary cultures of neurons can produce IFN-13 in response to TLR activation and whether this has any implication for protection against foreign pathogens.
TLR3 is expressed broadly in inflamed CNS tissue, and so far it appears to be the main, if not the only, TLR receptor expressed at physiologically relevant levels on nonmicroglia cells in the noninjured postnatal C NS. This is consistent with the fac t that microglia are the main, but not exclusive, sentinel of the C NS.
Functional Implication of TLRs in Mammalian Host Response
It is important to note that the contribution of TLR expression to protection against infections in the CNS is currently unclear. Until recently, there was not a single report showing that the loss of TLR expression in the brain parenchyma affects the replication of a pathogen or the survival of the infected host. One report suggests that TLRs [or other poly(I:C) receptorsJ can mediate a protective CNS response to vesicular stomatitis virus when hyperstimulated with poly(I:C) (De Clercq and De Somer, 1971) . Excitingly, it has now been reported that some patients suffering from herpes simplex encephalitis, caused by the neuroinvasion of herpes simplex virus 1 (HSV-1), express a dominant-negative mutation in the TLR3 gene (S .Y . . This mutation leads to the expression of dominant-negative TLR3, causing a dramatically decreased cellular IFN response to HSV -1 and vesicular stomatitis virus. The mutation did not affect the cellular response to a host of other viral infections, showing that the TLR3-mediated natural immunity to HSV-1 and VSV is selective. The authors suggest that the defects in the patients deficient in TLR3 signaling involves an intrinsic defect affecting CNS-residing cells, underscoring the importance of future research into the function of TLR3 in CNS immunity (S .Y. Zhang et aI., 2007) . The fact that only one report exists regarding the role of TLRs in protection of the C NS from pathogens points to a high degree of functional redundancy between different extracellular and intracellular PRR systems, especially when complex pathogens with multiple PAMPs are to be recognized.
c-Type Lectin Receptors as
Membrane-Associated PRRs
The C-type lectin receptors are a family of carbohydrate-recognizing PRRs. T he most well-studied member of the C-type lectins is the mannose receptor (MR; Stahl and Ezekowitz, 1998) . The MR is capable of recognizing gram-positive and· gram-negative bacteria, parasites, mycobacteria, and yeasts and has b een implicated in pathogen uptake and inflammatory responses (Stahl and Ezekowitz, 1998) .
MR protein expression was convincingly shown in primary cultures of human astrocytes, in murine and rat microglia, and in murine astrocytes and neurons in vivo (Marzolo et al., 1999; Burudi and Regnier-Vigouroux, 2001; Zimmer et al., 2003; Liu et aI., 2004) . However, in other studies, MR expression was found to be restricted to perivascular, meningeal, and choroid plexus macrophages (Fabriek et al., 2005; Galea et aI. , 2005) . T he MR binds the highly mannosylated envelop e glycoprotein gp120 and serves as a CD4-independent HIV-l entry receptor on astrocytes (Liu et aI., 2004) . Astrocyte-HIV-1 interaction induces MMP-2 through the MR, showing that the receptor is functional (L6pez-Herrera et al., 2005) . Surprisingly, MR expression on microglia is down-regulated by proinflammatory stimulation with LPS or IFN-' Y and up-regulated by stimulation with IL-4 or treatment with dexamethasone (Marzolo et aI., 1999; Zimmer et aI., 2003) . This is inconsistent with a role of MR in an inflanunatory setting, and indeed it has been shown in several infection models that MR does not playa crucial tole in fungal infections in vivo (Lee et aI. , 2003) . Macrophage uptake of the fungal pathogen Candida albicans was inhibited by l3-glucan and not by a -mannan (an MR antagonist), suggesting that fungal uptake was regulated by another l3-glucan-sensitive PRR (Lee et aI., 2003) . Recently, dectin-1 was identified as this receptor, and it was shown that dectin-deficient mice display severe deficits in their antifungal response (Taylor et al., 2007) . Dectin-1 and dectin-2 are C-type lectins important for the . recognition and inunune response to fungal cell wall constituents such as l3-glucans (Dostert and Tschopp, 2007) . However, under resting conditions, no dectins are expressed in the brain (Reid et al" 2004; Taylor et aI., 2005) , Dectin expression is up-regulated by proinflanunatory stimuli, Thus, it is possible that the receptors can be upregulated in inflamed CNS tissue, but this is yet to be shown (Taylor et aI., 2005) , Dendritic-cell-specific C-type ICAM3 grabbing nonintegrin (DC-SIGN)/CD163 is a C-type lectin PRR that is capable of detecting a multitude of pathogens, including virus, bacteria, fungus, parasites, and tumors (T. Zhou et aI., 2006) , Both DC-SIGN and dectin have been reported to modulate TLR signaling (T. Zhou et aI., 2006; Dostert and Tschopp, 2007) , DC-SIGN is commonly used as a marker for perivascular macrophages (sometimes described as CNS-residing dendritic cells) in CNS tissue of humans, mice, and monkeys , The receptor functions as an HIV -1 entry receptor, and the receptor is up-regulated in a few microglia and giant nucleated cells after an HIV-l infection in vivo , In addition, DC-SIGN is up-regulated in microglia and foamy macrophages in the brains of mice suffering from experimental autoimmune encephalomyelitis (EAE; Fabriek et aI., 2005) , Another PRR C-type lectin, Dec 205/CD205, displays a CNS expression pattern similar to that of DC-SIGN (Rosicarelli et al" 2005) , Few studies have investigated a possible protective role of C-type lectins in CNS infections,
Scavenger Receptors
Scavenger receptors (SR) are a diverse group of membrane proteins that share the capacity to bind modified low-density lipoproteins, The SRs can be broadly divided into eight different classes (A-H), and members of several classes have been shown to bind and mediate uptake or respond to a variety of pathogens (Murphy et aI., 2005) , Class A receptor SR-A mediates phagocytosis of gram-positive and gram-negative bacteria and clearance of endotoxin, SR macrophage receptor with collagenous structure (SR-MARCO) binds bacteria, and SR with C-type lectin (SRCL) mediates uptake of yeasts and gram-positive and gram-negative bacteria (Murphy et aI., 2005 , and references therein), SR-BJ binds LPS, and mutations or polymorphisms of the class B receptor CD36 are associated with protection against cerebral malaria (Omi et aI., 2003; Murphy et aI., 2005) , CD36 is expressed by microglia and mediates a ~-amyloid induced inflammatory microglia response (El Khoury et aI., 2003) , CD36-deficient mice are hypersusceptible to Staphylococcus aureus infection, and it was found that CD36 is a receptor for microbial diacylglycerides that signal via TLR2/6 (Hoebe et aI., 2005) , In contrast, the response to triacyl lipoproteins requires the presence of TLR1/TLR2 and CD14, but not CD36 (Triantafilou et aI., 2006) , Other scavenger receptors expressed or induced by inflammatory stimuli on microglia are SR-AIISRAII, SR-MARCO, SR-BI, SRCL, and receptor for advanced glycation endpoints (RAGE; Husemann The cytoplasmic family of nucleotide-binding oligomerization domain (NOD) proteins comprises important pattern recognition receptors for intracellular immune defense, The NODs are all characterized by three structural domains: 1) a carboxy (C) -terminal domain with multiple leucine-rich repeats (LRR) that recognizes ligands; 2) a central nucleotide binding site (NBS or Nacht domain), which is important for self-oligomerization and possess ATPase activity; and 3) an amino (N) -tenninal effector motif, the CARD domain, which is composed of protein-protein interaction cassettes leading to the activation of NF-KB and/or caspases upon NOD stimulation (Chamaillard et al" 2003a; Martinon and Tschopp, 2005) , Two prominent NOD family members, NODi (also called CARD 4) and NOD2 (also called CARD15) trigger activation of NF-KB and subsequent induction of inflammatory mediators, Only recently has an exclusive role of the RICK/RIP2 kinase for coupling of NOD to NF-KB been shown in RICKnull mice, displaying a defective response toward NODi and NOD2 agonists (Park et aI., 2007) , Both NODs are expressed in the cytosol, where they recognize muropeptides, building blocks of bacterial cell wall PGNs (Chamaillard et aI., 2003b; Girardin et aI., 2003a,c) , NODi was initially falsely described as an LPS receptor (Inohara et al" 2001) , as a result of muropeptide contamination of an LPS preparation, NOD2 recognizes as minimal active motif the muramyl dipeptide (MDP), which is present in both gram-negative and gram-positive PGN, NOD2, therefore, can be regarded as a broad bacterial sensor (Girardin et aI., 2003b) , After phagocytosis and treatment by lysosomal proteases, muropeptides may become available to intracellular proteins, but the precise route remains to be defined (Carneiro et aI., 2004) , Besides NOD, the family of NOD-like intracellular receptors also contains NALPl-3 and other members, but information on their role in neural cells is not yet available, The same applies to RIG-like helicases, another family of cytosolic PRR,
Interplay of NOD and TLR
Independently of the cell type used, all studies consistently describe a strong synergistic activity of NOD and TLR (for review see Traub et aI., 2006) , In the case of the TLR4 ligand LPS, NOD stimulation can result in a shift of the dose-response curve by a factor of 1,000 (Traub et aI., 2004) , It has to be noted that synergistic actions of TLR and NOD ligands already occur with low doses of stimuli. Although we do not know in which phase of an infection such synergy can develop, synergistic pathogenic stimuli through different immune receptors might be the rule rather than the exception.
Role of NOD for Neural Cells
Murine astrocytes as well as murine microglia cells constitutively express functional NOD2 protein, which is up-regulated by stimulation with Borrelia hurgdoiferi or Neisseria meningitides or by stimulation with TLR ligands (Sterka and Marriott, 2006; Sterka et aI., 2006) . Furthermore, both astrocytes and microglia express RICK kinase, which is crucial for NOD signaling (Park et aI., 2007) . Peripheral administration of the NOD2 ligand MDP, as with ligands for TLR3, TLR4, and TLR7/8, leads to proliferation of spinal cord cells in vivo, which is accompanied by activation of microglia cells (Su et aI., 2005) . MDP stimulation of rat astrocytes alone results in a mild release of nitric oxide, which is significantly increased by stimulation with a ligand of TLR1I2, TLR4, or TLR6 (Guo et aI., 2006) . The expression of the ionotropic purinergic P2X4 receptor is regulated in a similar fashion, but the most pronounced effect was observed for MDP-induced TNF release, which was markedly increased in presence of any of the TLR (TLRl-9) ligands investigated. However, the observed effects appeared to be additive rather than synergistic. Whether NOD2 signaling is protective or rather detrimental in an infection scenario and whether there are immune-modulating influences of TLR signaling remain to be determined.
Indirect PRRs
In addition to the recognition of P AMPs by membrane and intracellular receptors, nature has devised a different recognition strategy. Recognition may occur by soluble proteins, and these proteins, bound to their target, are then recognized by dedicated recognition receptors. Two major systems using this principle are the complement system and the immunoglobulin system. The latter bridges the gap between the innate and the adoptive immune system. Pathogen antigens can be recognized by millions of different antibodies, which are then in turn recognized by a small number of immunoglobulin receptors, which are also found on microglia cells (Peress et aI., 1993) , the most prominent being the Fc-gamma receptors . The complement system involves several levels of recognition and will therefore be described in more detail.
COMPLEMENT: A UNIQUE INNATE IMMUNE
SENSOR FOR DANGER SIGNALS The complement system is a central effector arm of the innate immune response consisting of some 30 fluidphase and cell-membrane-associated proteins involved in the recognition and killing of invading pathogens, the clearance of immune complexes and apoptotic cells, and the mediation of inflammation (Frank and Fries, 1991) .
More recently, complement has been shown to playa key role in eliciting and modulating adaptive immunity (Carroll, 2004; Hawlisch and Kohl, 2006; X. Zhang et aI., 2007) . The brain has been shown to synthesize a full and functional complement system (Morgan and Gasque, 1996) . The individual components are produced from diverse cell types, such as neurons, astrocytes, and microglia. There is now compelling evidence that complement activation in the brain is a double-edged sword, in that it can exert detrimental or beneficial effects depending on the pathophysiological context (Barnum, 2002; van Beek et aI., 2003) . More specifically, the complement system has recently emerged as one of the key players in innate immune recognition and clearance of pathogens and toxic entities by resident cells of the human brain (Gasque, 2003; Hauwell et aI., 2005) .
Complement can be activated through three distinct routes: the classical, alternative, and lectin pathways. Ultimately, activation of the entire complement cascade leads to the formation of the membrane attack complex (MAC), which forms a pore in the phosholipid bilayer of cells. The classical complement . pathway is activated primarily by the interaction of Clq with antibody-antigen complexes, C-reactive protein, and serum amyloid P protein of the pentraxin family, or ligands exposed on the surface of pathogens (Storrs et aI., 1983; Gewurz et aI., 1993) . Furthermore, Clq binds neuropathologically relevant ligands including f3-amyloid fibrils and apoptotic neurons in vitro (Tenner, 1999; TacnetDelorme et aI., 2001; Cole et aI., 2006) , suggesting an important role for Clq as sensor molecule that facilitates the clearance of a large variety of danger entities from the CNS (Hauwel et aI., 2005) .
The initiation of the alternative pathway does not require the presence of immune complexes and leads to the deposition of C3 fragments on target microorganisms. A third activation route involves mannose binding lectin (MBL) , a lectin homologous to Clq that recognizes polysaccharide structures of bacteria, fungi, viruses, and parasites (Turner, 2003) as well as apoptotic cells (Ogden et aI., 2001) and triggers the complement pathway independently of both the classical and the alternative activation pathways. Activation of the three complement pathways generates the fragments C3b and finally iC3b, two opsonins that flag the target cell to promote phagocytosis.
Complement Receptors Involved in Phagocytosis
The complement receptor CR3 (CDllb/CD18) recognizes C3b and iC3b and is expressed by microglia (Perry et aI., 1985; Akiyama and McGeer, 1990) . Additionally, CR3 directly recognizes pathogen surface molecules such as LPS and beta-glucan (Ross, 2002) and mediates the elimination of degenerated myelin by macrophages and microglia (Rotshenker, 2003) . The complement receptor CRl (CD35) also binds to Clq, C3b, iC3b, and MBL and, as such, has been implicated in phagocytic and complement regulatory activities (Krych-Goldberg and Atkinson, 2001) , whereas the complement receptors C3aR and CSaR have different immunomodulatory functions .
Regulation of Complement Activation
To protect "self' cells against bystander lysis, host cells express a battery of secreted or membrane-bound complement inhibitors. Membrane-associated complement inhibitors include membrane cofactor protein (MCP = CD46), decay-accelerating factor (DAF = CDSS), and CDS9. Notably, an inhibitor of complement activation termed "complement receptor-related protein y" (Crry) is expressed on rodent, but not on human, cell membranes. Crry is broadly distributed and is a functional and structural analog of human DAF and MCP. Wyss-Coray and colleagues (2002) 
Complement and CNS Bacterial Infection
Complement protein levels have been found to be elevated in the cerebrospinal fluid of patients with bacterial meningitis (Stahel et aI., 1997). Furthennore, deficiencies in, e.g., the alternative pathway seem to increase susceptibility to meningococcal disease, underscoring the importance of the complement-dependent defense against this particular pathogen (Speth et aI., 2002) . In patients with bacterial meningitis, recovery was correlated with higher levels of C4 and C3 in the cerebrospinal fluid (Zwahlen et aI., 1982) . The complement system also limits pneumococcal outgrowth in the CNS. Rabbits treated with cobra venom factor to deplete complement were found to be more susceptible to intracisternal inoculation of S. pneumoniae (Tuomanen et al., 1986) . More recently, Rupprecht and colleagues (2007) , using mice deficient in either C1q or C3, showed that complement is a central regulator of the innate immune response to pneumococcal CNS infection. However, given the multiple roles of the complement system, it has been difficult so far to identify their specific roles in the pathogenesis of CNS bacterial infection. Indeed, besides its role in the recognition and clearance of invading bacterial pathogens, the complement system has been shown to playa major role in the inflammatory response within the intrathecal compartment, thus possibly contributing to brain damage caused by an excessive inflammatory response (Stahel and .
Complement and Virus-Induced Encephalitis
The cerebral complement system has been hypothesized to contribute to neurodegeneration in the 1443 pathogenesis of acquired immune deficiency syndrome (AIDS) -associated neurological disorders (Speth et aI., 2002) . Complement synthesis by astrocytes is dramatically increased after infection with HIV. This observation is in line with data showing elevated complement in cerebrospinal fluid of patients with HIV infection Oongen et al., 2000) . Complement ac tivation may thus provide first-line brain immune defense by triggering lysis of virions and infected cells (Speth et aI., 2007) . In turn, HIV, either opsonized by complement or immunocomplexed, may bind to complement receptors expressed on the surface of astrocytes and microglia, thus favoring their infection, as observed in the periphery (Montefiori et aI., 1996) . Additionally, viruses can enter the brain by interacting with specific complement receptors expressed by neurons and glial cells: DAF for enteroviruses and echoviruses, CD21 for Epstein-Barr virus, emphasizing the critical role of the complement system in virus-induced encephalitis (Hauwell et aI., 2005) .
SUMMARY AND OUTLOOK
Many receptors associated with the detection of pathogens and the initiation of an immune response in the periphery are also expressed within the brain. The recent observation that PRR receptors are expressed not only by microglia but also by other CNS-residing cells suggests a role of these cells in pathogen detection. It will be exciting to find out whether these cells play a major role in initiating a protective CNS innate immune response and which PRRs contribute to it. In view of the immune-dampened status of the brain, it will also be interesting to see whether PRRs couple to the same signal transduction and response machinery as in the periphery and how far the inflammatory response correlates with the elimination of pathogens.
